Lensar (LNSR) Return on Capital Employed (2020 - 2026)
Lensar (LNSR) posted quarterly Return on Capital Employed of 32.43% for Q1 2026, down 39.0% year-over-year from 53.17% in Q1 2025, and up 60.09% quarter-over-quarter from 81.27% in Q4 2025.
Lensar (LNSR) Return on Capital Employed (2020 - 2026) Analysis & Trends
Lensar (LNSR) has reported Return on Capital Employed for 7 consecutive years, with 32.43% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 39.0% year-over-year to 32.43%; the TTM figure through Mar 2026 stood at 32.43% (down 39.0% YoY), while the FY2025 annual figure was 86.88%, down 6673.0% from the prior year.
- Return on Capital Employed climbed to 32.43% in Q1 2026 per LNSR's latest filing, from 81.27% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 18.67% in Q1 2024 and bottomed at 81.27% in Q4 2025.
- Historically, Return on Capital Employed has averaged 36.36% across 5 years, with a median of 32.43% in 2026.
- Annual changes were most pronounced in 2023 — Return on Capital Employed surged 2593 bps — and 2025, when it tumbled 5957 bps.
- Lensar's Return on Capital Employed stood at 45.96% in 2022, then surged by 55 bps to 20.87% in 2023, then decreased by 4 bps to 21.7% in 2024, then tumbled by 275 bps to 81.27% in 2025, then soared by 60 bps to 32.43% in 2026.
- Business Quant data shows LNSR's Return on Capital Employed at 32.43% in Q1 2026, 81.27% in Q4 2025, and 60.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 12.08% |
| 10 | Lensar | 101.45 Mn | 87.89 Mn | 9.78 Mn | -16.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.84% |
| Mar 31, 2026 | -32.43% |
| Dec 31, 2025 | -81.27% |
| Sep 30, 2025 | -60.57% |
| Jun 30, 2025 | -35.13% |
| Mar 31, 2025 | -32.05% |
| Dec 31, 2024 | -21.70% |
| Sep 30, 2024 | -24.65% |
| Jun 30, 2024 | -24.59% |
| Mar 31, 2024 | -18.67% |
| Dec 31, 2023 | -20.87% |
| Sep 30, 2023 | -19.80% |
| Jun 30, 2023 | -27.29% |
| Mar 31, 2023 | -40.66% |
| Dec 31, 2022 | -45.96% |
| Sep 30, 2022 | -45.73% |
| Jun 30, 2022 | -48.80% |
| Mar 31, 2022 | -38.00% |
| Dec 31, 2021 | -33.55% |
| Sep 30, 2021 | -36.28% |